BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 21689662)

  • 21. Dominant-negative effects in prion diseases: insights from molecular dynamics simulations on mouse prion protein chimeras.
    Cong X; Bongarzone S; Giachin G; Rossetti G; Carloni P; Legname G
    J Biomol Struct Dyn; 2013; 31(8):829-40. PubMed ID: 22934595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photo-induced crosslinking of prion protein oligomers and prions.
    Piening N; Weber P; Högen T; Beekes M; Kretzschmar H; Giese A
    Amyloid; 2006 Jun; 13(2):67-77. PubMed ID: 16911960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prion paradox: infection or polymerisation?
    Biro JC
    Appl Bioinformatics; 2003; 2(3 Suppl):S25-30. PubMed ID: 15130813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diverse effects on the native β-sheet of the human prion protein due to disease-associated mutations.
    Chen W; van der Kamp MW; Daggett V
    Biochemistry; 2010 Nov; 49(45):9874-81. PubMed ID: 20949975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prion protein biology.
    Prusiner SB; Scott MR; DeArmond SJ; Cohen FE
    Cell; 1998 May; 93(3):337-48. PubMed ID: 9590169
    [No Abstract]   [Full Text] [Related]  

  • 26. Aptamers against prion proteins and prions.
    Gilch S; Schätzl HM
    Cell Mol Life Sci; 2009 Aug; 66(15):2445-55. PubMed ID: 19396399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein.
    Telling GC; Scott M; Mastrianni J; Gabizon R; Torchia M; Cohen FE; DeArmond SJ; Prusiner SB
    Cell; 1995 Oct; 83(1):79-90. PubMed ID: 7553876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NMR structural studies of human cellular prion proteins.
    Biljan I; Ilc G; Giachin G; Legname G; Plavec J
    Curr Top Med Chem; 2013; 13(19):2407-18. PubMed ID: 24059340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Why are prion diseases precluded by non-mammals?
    Ji HF; Zhang HY; Chen LL
    Trends Biochem Sci; 2007 May; 32(5):206-8; discussion 208. PubMed ID: 17419063
    [No Abstract]   [Full Text] [Related]  

  • 30. The state of the prion.
    Weissmann C
    Nat Rev Microbiol; 2004 Nov; 2(11):861-71. PubMed ID: 15494743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant human prion protein mutants huPrP D178N/M129 (FFI) and huPrP+9OR (fCJD) reveal proteinase K resistance.
    Gauczynski S; Krasemann S; Bodemer W; Weiss S
    J Cell Sci; 2002 Nov; 115(Pt 21):4025-36. PubMed ID: 12356908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The H187R mutation of the human prion protein induces conversion of recombinant prion protein to the PrP(Sc)-like form.
    Hosszu LL; Tattum MH; Jones S; Trevitt CR; Wells MA; Waltho JP; Collinge J; Jackson GS; Clarke AR
    Biochemistry; 2010 Oct; 49(40):8729-38. PubMed ID: 20718410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
    Leliveld SR; Stitz L; Korth C
    Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying critical sites of PrP(c)-PrP(Sc) interaction in prion-infected cells by dominant-negative inhibition.
    Taguchi Y; Schätzl HM
    Prion; 2013; 7(6):452-6. PubMed ID: 24401595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy.
    Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K
    Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prion protein interconversions and the transmissible spongiform encephalopathies.
    Horiuchi M; Caughey B
    Structure; 1999 Oct; 7(10):R231-40. PubMed ID: 10545332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-function aspects of prion proteins.
    Daggett V
    Curr Opin Biotechnol; 1998 Aug; 9(4):359-65. PubMed ID: 9720262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early structural features in mammalian prion conformation conversion.
    Legname G
    Prion; 2012; 6(1):37-9. PubMed ID: 22453176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molecular pathogenesis of spongiform encephalopathy].
    Aguzzi A; Maddalena A; Brandner S; Klein M
    Pathologica; 1997 Oct; 89(5):481-90. PubMed ID: 9489393
    [No Abstract]   [Full Text] [Related]  

  • 40. Prion channel proteins and their role in vacuolation and neurodegenerative diseases.
    Kourie JI
    Eur Biophys J; 2002 Sep; 31(5):409-16. PubMed ID: 12202918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.